Gerhardt, C. C.; Romero, Ignacio A; Cancello, R.; Camoin, L. and Strosberg, A. D.
|DOI (Digital Object Identifier) Link:||http://doi.org/10.1016/S0303-7207(01)00394-X|
|Google Scholar:||Look up in Google Scholar|
In addition to their role in inflammation, cytokines like TNF alpha have been reported to regulate the adipose tissue function suggesting a role for these soluble mediators in metabolism. However, it is not known whether adipocytes have the capacity to secrete chemokines, a group of low molecular weight inflammatory mediators that control leukocyte migration into tissues. Here we show that primary cultures of human preadipocytes constitutively produce three chemokines, interleukin-8 (IL-8), macrophage inflammatory protein-1 alpha (MIP-1 alpha) and monocyte chemotactic protein-1 (MCP-1), while their level of expression is low in mature adipocytes. Upon TNF alpha treatment, the expression of all the three chemokines is upregulated in adipocytes differentiated in vitro. In addition, we describe the presence of seven different chemokine receptors, mainly in mature adipocytes, both in vitro and in human fat tissue sections. Prolonged stimulation of cultured human adipocytes with exogenous chemokines leads to a decrease in lipid content in association with the downregulation of PPAR gamma mRNA expression. Moreover, chemokines positively control the secretion of leptin, a hormone that regulates appetite, by a post-transcriptional mechanism. These findings reveal a new role for chemokines in the regulation of adipose tissue and suggest a novel therapeutic basis for the treatment of obesity, diabetes and cachexia. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
|Item Type:||Journal Article|
|Keywords:||IL-8; MCP-1; MIP1α; Chemokine receptors; Leptin; Insulin; Adipocytes; Obesity|
|Academic Unit/Department:||Science > Life, Health and Chemical Sciences
|Interdisciplinary Research Centre:||Biomedical Research Network (BRN)|
|Depositing User:||Astrid Peterkin|
|Date Deposited:||09 Feb 2007|
|Last Modified:||14 Jan 2016 16:27|
|Share this page:|